Code of Massachusetts Regulations
105 CMR - DEPARTMENT OF PUBLIC HEALTH
Title 105 CMR 120.000 - The Control of Radiation
GENERAL ADMINISTRATIVE REQUIREMENTS
Section 120.528 - Training for Experienced Radiation Safety Officer, Teletherapy or Medical Physicist, Authorized Medical Physicist, Authorized User, Nuclear Pharmacist, and Authorized Nuclear Pharmacist
Universal Citation: 105 CMR 120.000 MA Code of Regs 120.528
Current through Register 1531, September 27, 2024
(A)
(1) An individual identified on an Agency,
Nuclear Regulatory Commission or Agreement State license or a permit issued by
an Agency, Nuclear Regulatory Commission or Agreement State broad scope
licensee or master material license permit or by a master material license
permittee of broad scope as a Radiation Safety Officer, a teletherapy or
medical physicist, an authorized medical physicist, a nuclear pharmacist or an
authorized nuclear pharmacist on or before January 14, 2019 need not comply
with the training requirements of
105 CMR
120.524,
120.525,
or
120.526,
respectively, except the Radiation Safety Officers and authorized medical
physicists identified in 105 CMR 120.528(A)(1) must meet the training
requirements in
105 CMR
120.524(D) or
120.525(C),
as appropriate, for any material or uses for which they were not authorized
prior to this date.
(2) Any
individual certified by the American Board of Health Physics in Comprehensive
Health Physics; American Board of Radiology; American Board of Nuclear
Medicine; American Board of Science in Nuclear Medicine; Board of
Pharmaceutical Specialties in Nuclear Pharmacy; American Board of Medical
Physics in radiation oncology physics; Royal College of Physicians and Surgeons
of Canada in nuclear medicine; American Osteopathic Board of Radiology; or
American Osteopathic Board of Nuclear Medicine on or before October 24, 2005,
need not comply with the training requirements of
105 CMR
120.524 to be identified as a Radiation
Safety Officer or as an Associate Radiation Safety Officer on an Agency,
Nuclear Regulatory Commission or Agreement State license or Nuclear Regulatory
Commission master material license permit for those materials and uses that
these individuals performed on or before October 24, 2005.
(3) Any individual certified by the American
Board of Radiology in therapeutic radiological physics, Roentgen ray and gamma
ray physics, X-ray and radium physics, or radiological physics, or certified by
the American Board of Medical Physics in radiation oncology physics, on or
before October 24, 2005, need not comply with the training requirements for an
authorized medical physicist described in
105 CMR
120.525, for those materials and uses that
these individuals performed on or before October 24, 2005.
(4) A Radiation Safety Officer, a medical
physicist, or a nuclear pharmacist, who used only accelerator-produced
radioactive materials, discrete sources of radium-226, or both, for medical
uses or in the practice of nuclear pharmacy at a Federal Government agency or
Federally recognized Indian Tribe before November 30, 2007 or at all other
locations of use before August 8, 2009, or an earlier date as noticed by the
NRC, need not comply with the training requirements of
105 CMR
120.524,
120.525
or
120.526,
respectively, when performing the same uses. A nuclear pharmacist, who prepared
only radioactive drugs containing accelerator-produced radioactive materials,
or a medical physicist, who used only accelerator-produced radioactive
materials, at the locations and during the time period identified in 105 CMR
120.528(A)(4), qualifies as an authorized nuclear pharmacist or an authorized
medical physicist, respectively, for those materials and uses performed before
these dates, for the purposes of
105 CMR
120.500.
(B)
(1)
Physicians, dentists, or podiatrists identified as authorized users for the
medical use of byproduct material on a license issued by the Agency, Nuclear
Regulatory Commission or an Agreement State, a permit issued by a Nuclear
Regulatory Commission master material licensee, a permit issued by the Agency,
Nuclear Regulatory Commission or an Agreement State broad scope licensee, or a
permit issued by a Nuclear Regulatory Commission master material license broad
scope permittee on or before January 14, 2019, who perform only those medical
uses for which they were authorized on or before that date need not comply with
the training requirements of
105 CMR
120.546,
120.551,
120.556,
120.557,
120.558,
120.558A,
120.566,
120.567,
120.569
and
120.587.
(2) Physicians, dentists, or podiatrists not
identified as authorized users for the medical use of byproduct material on a
license issued by the Agency, Nuclear Regulatory Commission or an Agreement
State, a permit issued by a Nuclear Regulatory Commission master material
licensee, a permit issued by the Agency, Nuclear Regulatory Commission or an
Agreement State broad scope licensee, or a permit issued by a Nuclear
Regulatory Commission master material license of broad scope on or before
October 24, 2005, need not comply with the training requirements of
105 CMR
120.546,
120.551,
120.556,
120.557,
120.558,
120.558A,
120.566,
120.567,
120.569
and
120.587
for those materials and uses that these individuals performed on or before
October 24, 2005, as follows:
(a) For uses
authorized under
105
CMR 120.544 or
120.547,
or oral administration of sodium iodide I-131 requiring a written directive for
imaging and localization purposes, a physician who was certified on or before
October 24, 2005, in nuclear medicine by the American Board of Nuclear
Medicine; diagnostic radiology by the American Board of Radiology; diagnostic
radiology or radiology by the American Osteopathic Board of Radiology; nuclear
medicine by the Royal College of Physicians and Surgeons of Canada; or American
Osteopathic Board of Nuclear Medicine in nuclear medicine;
(b) For uses authorized under
105
CMR 120.552, a physician who was certified on
or before October 24, 2005, by the American Board of Nuclear Medicine; the
American Board of Radiology in radiology, therapeutic radiology, or radiation
oncology; nuclear medicine by the Royal College of Physicians and Surgeons of
Canada; or the American Osteopathic Board of Radiology after 1984;
(c) For uses authorized under
105 CMR
120.559 or
120.570,
a physician who was certified on or before October 24, 2005, in radiology,
therapeutic radiology or radiation oncology by the American Board of Radiology;
radiation oncology by the American Osteopathic Board of Radiology; radiology,
with specialization in radiotherapy, as a British "Fellow of the Faculty of
Radiology'' or "Fellow of the Royal College of Radiology''; or therapeutic
radiology by the Canadian Royal College of Physicians and Surgeons;
and
(d) For uses authorized under
105 CMR
120.568, a physician who was certified on or
before October 24, 2005, in radiology, diagnostic radiology, therapeutic
radiology, or radiation oncology by the American Board of Radiology; nuclear
medicine by the American Board of Nuclear Medicine; diagnostic radiology or
radiology by the American Osteopathic Board of Radiology; or nuclear medicine
by the Royal College of Physicians and Surgeons of Canada.
(3) Physicians, dentists, or podiatrists who
used only accelerator-produced radioactive materials, discrete sources of
radium-226, or both, for medical uses performed at a Government agency or
Federally recognized Indian Tribe before November 30, 2007, or at all other
locations of use before August 8, 2009, or an earlier date as noticed by the
NRC, need not comply with the training requirements of
105 CMR
120.546,
120.551,
120.556,
120.557,
120.558,
120.558A,
120.566,
120.567,
120.569
and
120.587
when performing the same medical uses. A physician, dentist, or podiatrist, who
used only accelerator-produced radioactive materials, discrete sources of
radium-226, or both, for medical uses at the locations and time period
identified in 105 CMR 120.528(B)(3), qualifies as an authorized user for those
materials and uses performed before these dates, for the purposes of
105 CMR
120.500.
(C) Individuals who need not comply with training requirements as described in 105 CMR 120.528 may serve as preceptors for, and supervisors of, applicants seeking authorization on Agency licenses for the same uses for which these individuals are authorized.
Disclaimer: These regulations may not be the most recent version. Massachusetts may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.